Breakout B: Liver Cancer

This session will provide the tools needed for correct identification and prognostication of patients undergoing early liver transplantation for severe alcohol-associated liver disease. Additionally, attendees will gain an understanding of the keys of psy

Part 3: Endoscopic management for cancer screening in Cirrhotics and Pre-transplant -candidates

Part 4: Endoscopic management of complex diseases in Cirrhotics and Pre-transplant candidates

The goal of this program is equip clinical and translational researchers with the tools and framework to apply towards advancing biomarker research in alcohol-associated liver disease (ALD). This program will provide an overview of biomarker categories an

The session will review specific clinical practice challenges hepatology specialist may encounter, including optimizing cirrhotic patients for surgery, estimating MASLD fibrosis severity using non-invasive measures, determining the best time span to utili

Part 3: Bile acids in the brain liver axis

In this joint symposium of the JSH and AASLD, attendees will hear an international perspective to address the important topics of high-risk organ donation and non-invasive evaluation of chronic liver disease. Experts will present the current state of the

Breakout A: Non Alcoholic and Alcohol Induced Liver Disease

Speakers will share up-to-date models and techniques on the molecular and cellular mechanisms governing cell-to-cell communications in liver biology and diseases. During this discussion, attendees will learn how liver cell functions could be reprogrammed